Selective activation of PPAR-δ alleviates cognitive decline in mouse models of Alzheimer’s Disease(Malm et al., 2015) and type II diabetes mellitus(Abdel-Rahman et al., 2019). The gene discussed is PPARD; the disease is Mental deterioration.